Vaxart, Inc.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $16.3M | $-66.9M | $-82.5M | $-107.8M | $-70.5M | $-32.2M | $-18.6M | $-18.0M |
| Depreciation & Amortization | $8.6M | $8.9M | $8.6M | $5.8M | $4.2M | $2.7M | $3.6M | $3.2M |
| Depreciation | $3.5M | $3.7M | $3.8M | $2.0M | $732.0K | $114.0K | $504.0K | $476.0K |
| Amortization | $700.0K | $700.0K | $700.0K | $1.3M | $1.7M | $1.7M | $2.3M | $2.7M |
| Stock-Based Compensation | $8.3M | $11.5M | $14.1M | $13.6M | $8.9M | $4.4M | $627.0K | $539.0K |
| Net Cash from Operating Activities | $7.7M | $-44.8M | $-70.5M | $-94.8M | $-59.8M | $-23.8M | $-13.1M | $-14.5M |
| Investing Activities | ||||||||
| Capital Expenditures | $145.0K | $554.0K | $1.9M | $9.6M | $5.2M | $1.2M | $850.0K | $707.0K |
| Business Acquisitions | — | — | — | $0 | $4.8M | — | — | $21.0K |
| Net Cash from Investing Activities | $16.6M | $-21.3M | $44.0M | $-20.4M | $-49.1M | $-1.2M | $-850.0K | $26.2M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $4.2M | $56.6M | $15.2M | $17.5M | $125.8M | $138.3M | $16.0M | $-1.7M |
| Net Change in Cash | $28.6M | $-9.5M | $-11.3M | $-97.7M | $16.9M | $113.3M | $2.0M | $9.9M |
| Free Cash Flow | $7.6M | $-45.3M | $-72.3M | $-104.4M | $-65.0M | $-25.0M | $-13.9M | $-15.3M |
Those who do not remember the past are condemned to repeat it.